Zydus Lifesciences Limited (NSE: ZYDUSLIFE)
1,100.00
-15.15 (-1.36%)
Sep 6, 2024, 3:30 PM IST
Zydus Lifesciences Revenue
Zydus Lifesciences had revenue of 62.08B INR in the quarter ending June 30, 2024, with 20.78% growth. This brings the company's revenue in the last twelve months to 206.15B, up 11.96% year-over-year. In the fiscal year ending March 31, 2024, Zydus Lifesciences had annual revenue of 195.47B with 13.40% growth.
Revenue (ttm)
206.15B
Revenue Growth
+11.96%
P/S Ratio
5.39
Revenue / Employee
7.66M
Employees
26,921
Market Cap
1,106.86B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 195.47B | 23.10B | 13.40% |
Mar 31, 2023 | 172.37B | 21.28B | 14.08% |
Mar 31, 2022 | 151.10B | 7.06B | 4.90% |
Mar 31, 2021 | 144.04B | 1.50B | 1.06% |
Mar 31, 2020 | 142.53B | 10.88B | 8.26% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries Limited | 9,252.89B |
Tata Consultancy Services Limited | 2,441.25B |
HDFC Bank Limited | 2,663.37B |
Bharti Airtel Limited | 1,510.49B |
ICICI Bank Limited | 1,686.78B |
Infosys Limited | 1,555.41B |
State Bank of India | 3,319.63B |
Hindustan Unilever Limited | 621.07B |
Zydus Lifesciences News
- 4 days ago - Zydus Lifesciences gets warning letter from USFDA for injectables manufacturing facility at Jarod - Business Upturn
- 8 days ago - Zydus’ injectables mfg plant gets USFDA warning letter - The Times of India
- 8 days ago - Zydus Lifesciences gets warning letter from USFDA relating to its injectables manufacturing facility in Jarod - Business Upturn
- 8 days ago - Zydus Lifesciences receives US FDA approval for Scopolamine Patch, eyeing $69.6 Million US Market - Business Upturn
- 8 days ago - Zydus Lifesciences stock surges over 2% following Sterling Biotech stake acquisition - Business Upturn
- 8 days ago - Zydus Lifesciences completes acquisition of 50% stake in Sterling Biotech - Business Upturn
- 12 days ago - Stocks to Watch: Medi Assist, HCLTech, Zydus Lifesciences, Ultra Tech, HUL shares in focus Today, 27 Aug, 2024 - Business Upturn
- 12 days ago - Stock Market Today: Top gainers and losers in market today, August 26, 2024; KEC International, NIIT, ONGC, Paytm, Zydus Lifesciences and more - Business Upturn